Non-progressive placental abruption in incomplete pregnancy: aspects of diagnostic-therapeutic tactics
Keywords:pregnancy, placental abruption, hemostasis, tranexamic acid
Questions of accompany pregnancy with non-progressive partial placental abruption in incomplete pregnancy remain relevant for a long time and concern, in particular, the safety and efficacy of the use of hemostatic agents.
A study involving 127 patients with placental insufficiency, who were hospitalized at 22–26 weeks of gestation with signs of placental abruption was performed.
Patients were randomized into two groups: 32 pregnant of main group received tranexamic acid (drug Tranexam) as a hemostatic therapy, 15 patients of comparison group received etamsylatum.
As a result, it was found that the drug Tranexam in average daily doses (750–1 000 mg/day) for treatment duration of 5–7 days has more pronounced hemostatic effect, does not cause side effects, thus successfully maintain the pregnancy
- Bilyk, N.M. “Pregnancy in women with risk of premature detachment of the placenta at prophylactic treatment.” Women’s Health, 1(2007):94-96.
- Demina, T.N., Chaika, K.V. “Determination of D-dimer to predict thrombotic complications in pregnant and postpartum women at risk group.” Medical and Social Problems of the Family, 11(4) (2006):24-32.
- Serov, V.N., Sukhikh, G.T. “Clinical recommendations. Obstetrics and gynecology.” M: GEOTAR -Media (2014):488-497.
- Murashko, A.V., Kravchenko, N.F., Gribanova, N.D. “Hemorheological disorders in hypertension during pregnancy and their possible correction.” Gynecology, 9(5) (2007):17-19.
- Sidelnikova, V.M., Kiryushchenkov, P.A.
- Haemostasis and pregnancy. M.: Triada-X (2004).
- Tingborn, L. “Inhibitors of fibrinolysis in the treatment of hemorrhagic disorders.” Hemophilia Treatment, 42 (2007).
- Shevchenko, Y.L., et al. “Effect of blood saving of tranexamic acid.” Farmateka, 16(2008):17-25.
- De Lange, N.M., Lancé, M.D., de Groot, R., et al. “Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage.” Obstet. Gynecol. Surv., 67(7) (2012):426-435.
- Peitsidis, P., Kadir, R.A. “Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum.” Expert Opin. Pharmacother, 12(4) (2011):503-516.
- Rasmussen, S., Irgens, L.M. “Occurrence of placental abruption in relatives.” BJOG, 116(5) (2009):693.
- Su, L.L., Chong, Y.S. “Massive obstetric haemorrhage with disseminated intravascular coagulopathy.” Best Pract. Res. Clin. Obstet. Gynaecol, 26(1) (2012):77-90.
- Tower, C.L., Regan, L. “Intrauterine haematomas in a recurrent miscarriage population.” Hum. Reprod, 16(9) (2001):2005-2007.
- Van Oppenraaij, R.H., Jauniaux, E., Christiansen, O.B., et al. “Predicting adverse obstetric outcome after early pregnancy events and complications: a review.” Hum. Reprod. Update, 15(4) (2009):409-421.
How to Cite
Copyright (c) 2015 В. І. Пирогова, З. В. Сміх
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.